Paul J. Clancy - Feb 6, 2025 Form 3 Insider Report for Sionna Therapeutics, Inc. (SION)

Role
Director
Signature
/s/ Jennifer Fitzpatrick, Attorney-in-Fact
Stock symbol
SION
Transactions as of
Feb 6, 2025
Transactions value $
$0
Form type
3
Date filed
2/6/2025, 09:02 PM
Previous filing
Jan 3, 2025
Next filing
Apr 2, 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding SION Stock Option (Right to Buy) Feb 6, 2025 Common Stock 120K $6.11 Direct F1
holding SION Stock Option (Right to Buy) Feb 6, 2025 Common Stock 65.7K $6.11 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares underlying this option vest in sixteen equal quarterly installments following June 6, 2022, subject to the Reporting Person's continued service on each such vesting date.
F2 The shares underlying this option vest in forty-eight equal monthly installments following March 4, 2024, subject to the Reporting Person's continued service on each such vesting date.

Remarks:

Exhibit 24 - Power of Attorney